Schizophrenia (SCZ) and major depressive disorder (MDD) in treatment‐naive patients are
associated with increased risk for type 2 diabetes (T2D) and metabolic syndrome (MetS) …

Prodromal symptoms of bipolar disorder (BD) and early onset schizophrenia spectrum
disorder (EOSSD) overlap. To date, there has been no study directly comparing the …

Objectives: Although neuroanatomical abnormalities in subjects at clinical high risk for
psychosis have been considered a putative biomarker of psychosis, relevance of cortical …

Aim Recent studies have highlighted that attenuated psychotic symptoms (APS) are an
important source of distress in ultra high risk (UHR) individuals and that this distress is …

Introduction: The prevention of schizophrenia and other psychotic disorders has led
researchers to focus on early identification of individuals at clinical high risk (CHR) for …

Schizophrenia is conceptualized as a neurodevelopmental disorder and pre-morbid
differences in social function and cognition have been well-established. Less is known …

Background: To determine the 2-year clinical and functional outcomes of an Asian cohort at
ultra-high risk (UHR) of psychosis. Method: This was a longitudinal study with a follow-up …

There has been recent accumulation of evidence and clinical guidance regarding the at-risk
mental state (ARMS) for psychosis. However, most studies have been observational cohort …

Disturbances in cognitive functioning, such as poor concentration and memory, slowed
speed of information processing, or difficulty organising one's thoughts are commonly …

Current understanding of psychosis development is relevant to patients' clinical outcomes in
mental health services as a whole, given that psychotic symptoms can be a feature of many …